doi: 10.1111/imm.13423 229 WangYLiuHZhaoJ
(PubMed) Lee IC, Kim SH, Baek HS, et al
The laser therapy has helped her to reduce her inflammation and pain in that area
Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
The ferric reducing antioxidant power (FRAP) assay measures the reduction of the ferric 2,4,6-tripyridyl-s-triazine complex [Fe 3+ -(TPTZ) 2 ] 3+ to the blue ferrous complex [Fe 2+ -(TPTZ) 2 ] 2+ by antioxidants in acidic medium (pH 3.6), monitored by absorbance increase at 593 nm ( 3.1.4 Stabilization of free radical scavenging The 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay quantifies antioxidant capacity by measuring the reduction of the stable DPPH radical through hydrogen atom transfer (HAT) or electron transfer (ET) mechanisms
